| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.43B | 13.22B | 13.43B | 10.10B | 9.19B | 7.08B |
| Gross Profit | 12.42B | 12.71B | 13.30B | 9.58B | 8.45B | 6.57B |
| EBITDA | 6.36B | 6.17B | 7.02B | 4.70B | 3.89B | 2.61B |
| Net Income | 4.14B | 4.24B | 4.55B | 3.33B | 3.22B | 2.19B |
Balance Sheet | ||||||
| Total Assets | 133.14B | 165.76B | 125.05B | 118.19B | 88.32B | 74.10B |
| Cash, Cash Equivalents and Short-Term Investments | 8.45B | 8.50B | 12.12B | 8.85B | 5.78B | 6.37B |
| Total Debt | 1.03B | 1.20B | 1.13B | 2.23B | 2.10B | 2.06B |
| Total Liabilities | 115.98B | 145.87B | 107.63B | 104.08B | 76.34B | 64.85B |
| Stockholders Equity | 17.16B | 19.88B | 17.41B | 14.12B | 11.97B | 9.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 37.51B | 6.99B | 5.11B | 692.00M | 578.00M |
| Operating Cash Flow | 0.00 | 37.60B | 6.47B | 5.17B | 1.32B | 849.00M |
| Investing Cash Flow | 0.00 | -871.00M | -607.00M | -329.00M | -729.00M | -146.00M |
| Financing Cash Flow | 0.00 | -1.97B | -2.58B | -1.28B | -590.00M | 73.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥33.30B | 4.48 | ― | 3.91% | -1.58% | -3.33% | |
77 Outperform | ¥85.73B | 6.96 | ― | 5.75% | 30.59% | 55.29% | |
70 Outperform | ¥200.00B | 4.29 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | ¥44.71B | 16.68 | ― | 4.36% | 3.23% | -11.76% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥233.66B | 13.77 | 14.00% | 5.13% | 34.33% | 47.34% | |
43 Neutral | ¥167.32B | 13.27 | 7.26% | 4.16% | 9.77% | -52.42% |